Non-alcoholic fatty liver disease: Insights from sphingolipidomics

Area of Science:

• Hepatology and metabolic disease research.
• Biochemistry and lipidomics.

Background:

• Non-alcoholic fatty liver disease (NAFLD) is a significant health issue with substantial healthcare costs.
• Lipid accumulation initiates NAFLD, but inflammation, fibrosis, and cirrhosis are key pathological drivers.
• The precise mechanisms linking lipid overload to disease progression remain unclear, with bioactive lipid metabolism implicated in proinflammatory signaling.

Purpose of the Study:

• To explore the role of bioactive lipid metabolism in NAFLD pathogenesis.
• To investigate sphingolipids as potential markers for NAFLD progression.
• To leverage advanced lipidomics for understanding NAFLD.

Main Methods:

• Utilizing high-throughput, sensitive, and quantitative mass spectrometry for lipid profiling.
• Analyzing lipid profiles in human biopsies and plasma, as well as animal models.
• Employing both targeted and unbiased lipidomics approaches.

Main Results:

• Increased levels of specific sphingolipids correlate with the progression from simple fatty liver to inflamed NAFLD.
• Mass spectrometry-based lipid profiling reveals trends associated with disease severity.
• Sphingolipid alterations are linked to the transition from benign steatosis to inflammatory liver disease.

Conclusions:

• Sphingolipid profiling is a promising tool for identifying enzymes and pathways involved in NAFLD.
• Sphingolipids may serve as crucial biomarkers for NAFLD progression and inflammation.
• Further research using unbiased lipidomics can enhance understanding of sphingolipids' roles in NAFLD.